The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 13, 2021
Filed:
Oct. 03, 2018
Applicant:
Nestec S.a., Vevey, CH;
Inventor:
Yuanlong Pan, Chesterfield, MO (US);
Assignee:
SOCIÉTÉ DES PRODUITS NESTLÉ S. A., Vevey, CH;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/60 (2006.01); A61K 45/06 (2006.01); A23D 9/007 (2006.01); A61K 31/522 (2006.01); A61K 31/454 (2006.01); A23K 50/40 (2016.01); A61K 31/22 (2006.01); A61K 31/20 (2006.01); A61K 31/445 (2006.01); A23K 20/158 (2016.01); A23L 33/12 (2016.01); A61K 31/4375 (2006.01); A23L 33/115 (2016.01); A23L 33/175 (2016.01); A23K 10/18 (2016.01); A61K 31/55 (2006.01); A61K 36/16 (2006.01); A61K 31/683 (2006.01); A61K 31/675 (2006.01); A61K 31/54 (2006.01); A61K 31/56 (2006.01); A61K 31/663 (2006.01); A61K 31/198 (2006.01); A61K 31/202 (2006.01);
U.S. Cl.
CPC ...
A61K 35/60 (2013.01); A23D 9/007 (2013.01); A23K 10/18 (2016.05); A23K 20/158 (2016.05); A23K 50/40 (2016.05); A23L 33/115 (2016.08); A23L 33/12 (2016.08); A23L 33/175 (2016.08); A61K 31/198 (2013.01); A61K 31/20 (2013.01); A61K 31/202 (2013.01); A61K 31/22 (2013.01); A61K 31/4375 (2013.01); A61K 31/445 (2013.01); A61K 31/454 (2013.01); A61K 31/522 (2013.01); A61K 31/54 (2013.01); A61K 31/55 (2013.01); A61K 31/56 (2013.01); A61K 31/663 (2013.01); A61K 31/675 (2013.01); A61K 31/683 (2013.01); A61K 36/16 (2013.01); A61K 45/06 (2013.01);
Abstract
Compositions include arginine and one or more unsaturated fatty acids. Methods for using such compositions can enhance cognitive function, reduce or prevent a decline of social interaction, reduce or prevent age-related behavioral changes, increase trainability, maintain optimal brain function, facilitate learning and memory, reduce memory loss, retard brain aging, prevent or treat strokes, and/or prevent or treat dementia in an animal. Preferably, the compositions are food compositions useful for enhancing cognitive function in humans and companion animals.